{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T12:30:17Z","timestamp":1712925017983},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,19]]},"DOI":"10.7759\/cureus.26083","type":"journal-article","created":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T12:28:02Z","timestamp":1655641682000},"source":"Crossref","is-referenced-by-count":2,"title":["Fournier\u2019s Gangrene in an HIV-Positive Patient on Empagliflozin for the Treatment of Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Farzam","family":"Khokhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0777-3","article-title":"Fournier's gangrene: risk factors and strategies for management","volume":"30","author":"Yanar H","year":"2006","unstructured":"Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I. Fournier's gangrene: risk factors and strategies for management. World J Surg. 2006, 30:1750-4. 10.1007\/s00268-005-0777-3","journal-title":"World J Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_159_17","article-title":"Genital infections with sodium glucose cotransporter-2 inhibitors: occurrence and management in patients with type 2 diabetes mellitus","volume":"22","author":"Unnikrishnan AG","year":"2018","unstructured":"Unnikrishnan AG, Kalra S, Purandare V, Vasnawala H. Genital infections with sodium glucose cotransporter-2 inhibitors: occurrence and management in patients with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018, 22:837-42. 10.4103\/ijem.IJEM_159_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref3","article-title":"Empagliflozin (EMPA) increases genital infections but not urinary tract infections in pooled data from four pivotal phase III trials","volume":"9","author":"Kim G","year":"2014","unstructured":"Kim G, Gerich J, Salsali A, Hach T, Hantel S, Woerle HJ, Broedl UC. Empagliflozin (EMPA) increases genital infections but not urinary tract infections in pooled data from four pivotal phase III trials. Diabetologie und Stoffweschel. 2014, 9:140.","journal-title":"Diabetologie und Stoffweschel"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s","volume":"52","author":"Torriani FJ","year":"2008","unstructured":"Torriani FJ, Komarow L, Parker RA, et al.. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008, 52:569-76. 10.1016\/j.jacc.2008.04.049","journal-title":"J Am Coll Cardiol"},{"key":"ref5","article-title":"Impact of immunodeficiency virus (HIV) on Fournier's gangrene: observations in Zambia","volume":"77","author":"Elem B","year":"1995","unstructured":"Elem B, Ranjan P. Impact of immunodeficiency virus (HIV) on Fournier's gangrene: observations in Zambia. Ann R Coll Surg Engl. 1995, 77:283-6.","journal-title":"Ann R Coll Surg Engl"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100819-fourniers-gangrene-in-an-hiv-positive-patient-on-empagliflozin-for-the-treatment-of-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:31Z","timestamp":1707507931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100819-fourniers-gangrene-in-an-hiv-positive-patient-on-empagliflozin-for-the-treatment-of-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,19]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.26083","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,19]]}}}